![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLEC4F mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLEC4F mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLEC4F mRNA | CTD | PMID:21570461, PMID:28922406 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:621062 | 6480464 | 1, 2-dithiol-3-thione results in decreased expression of CLEC4F mRNA | CTD | PMID:19162173 | aflatoxin B1 | decreases expression | ISO | RGD:621062 | 6480464 | Aflatoxin B1 results in decreased expression of CLEC4F mRNA | CTD | PMID:23630614, PMID:25378103 | ammonium chloride | affects expression | ISO | RGD:621062 | 6480464 | Ammonium Chloride affects the expression of CLEC4F mRNA | CTD | PMID:16483693 | amphetamine | increases expression | ISO | RGD:621062 | 6480464 | Amphetamine results in increased expression of CLEC4F mRNA | CTD | PMID:30779732 | benzo[a]pyrene | affects methylation | ISO | RGD:1354444 | 6480464 | Benzoapyrene affects the methylation of CLEC4F exon | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | RGD:1354444 | 6480464 | benzoepyrene results in increased methylation of CLEC4F intron | CTD | PMID:30157460 | bisphenol A | affects expression | ISO | RGD:621062 | 6480464 | bisphenol A affects the expression of CLEC4F mRNA | CTD | PMID:30903817 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CLEC4F mRNA | CTD | PMID:30245210 | buspirone | decreases expression | ISO | RGD:621062 | 6480464 | Buspirone results in decreased expression of CLEC4F mRNA | CTD | PMID:24136188 | cadmium dichloride | decreases expression | ISO | RGD:621062 | 6480464 | Cadmium Chloride results in decreased expression of CLEC4F mRNA | CTD | PMID:25993096 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | chrysene | decreases expression | EXP | | 6480464 | chrysene results in decreased expression of CLEC4F mRNA | CTD | PMID:26377693 | clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CLEC4F mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CLEC4F mRNA] | CTD | PMID:17585979 | cocaine | affects expression | ISO | RGD:621062 | 6480464 | Cocaine affects the expression of CLEC4F mRNA | CTD | PMID:20187946 | decabromodiphenyl ether | increases expression | ISO | RGD:621062 | 6480464 | decabromobiphenyl ether results in increased expression of CLEC4F mRNA | CTD | PMID:23914054 | Echimidine | decreases expression | ISO | RGD:621062 | 6480464 | echimidine results in decreased expression of CLEC4F mRNA | CTD | PMID:32419051 | ethanol | multiple interactions | ISO | RGD:621062 | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of CLEC4F mRNA | CTD | PMID:17347304 | flutamide | decreases expression | ISO | RGD:621062 | 6480464 | Flutamide results in decreased expression of CLEC4F mRNA | CTD | PMID:24136188 | fumonisin B1 | increases expression | EXP | | 6480464 | fumonisin B1 results in increased expression of CLEC4F mRNA | CTD | PMID:16221962 | Heliotrine | decreases expression | ISO | RGD:621062 | 6480464 | heliotrine results in decreased expression of CLEC4F mRNA | CTD | PMID:32419051 | hexachlorobenzene | increases expression | ISO | RGD:621062 | 6480464 | Hexachlorobenzene results in increased expression of CLEC4F mRNA | CTD | PMID:15159207 | Lasiocarpine | decreases expression | ISO | RGD:621062 | 6480464 | lasiocarpine results in decreased expression of CLEC4F mRNA | CTD | PMID:32419051 | manganese(II) chloride | increases methylation | ISO | RGD:621062 | 6480464 | manganese chloride results in increased methylation of CLEC4F gene | CTD | PMID:28801915 | methapyrilene | increases methylation | ISO | RGD:1354444 | 6480464 | Methapyrilene results in increased methylation of CLEC4F intron | CTD | PMID:30157460 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CLEC4F mRNA | CTD | PMID:24535843 | N-nitrosodiethylamine | decreases expression | ISO | RGD:621062 | 6480464 | Diethylnitrosamine results in decreased expression of CLEC4F mRNA | CTD | PMID:19041683 | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CLEC4F mRNA | CTD | PMID:24535843 | nefazodone | decreases expression | ISO | RGD:621062 | 6480464 | nefazodone results in decreased expression of CLEC4F mRNA | CTD | PMID:24136188 | nickel atom | decreases expression | ISO | RGD:1354444 | 6480464 | Nickel results in decreased expression of CLEC4F mRNA | CTD | PMID:25583101 | nimesulide | decreases expression | ISO | RGD:621062 | 6480464 | nimesulide results in decreased expression of CLEC4F mRNA | CTD | PMID:24136188 | paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CLEC4F mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CLEC4F mRNA] | CTD | PMID:17585979 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CLEC4F mRNA | CTD | PMID:17562736 | perfluorooctanoic acid | decreases expression | ISO | RGD:621062 | 6480464 | perfluorooctanoic acid results in decreased expression of CLEC4F mRNA | CTD | PMID:19162173 | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of CLEC4F mRNA, NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CLEC4F mRNA] | CTD | PMID:19482888, PMID:24535843 | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CLEC4F mRNA | CTD | PMID:19482888 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CLEC4F mRNA | CTD | PMID:11798191 | pirinixic acid | decreases expression | ISO | RGD:621062 | 6480464 | pirinixic acid results in decreased expression of CLEC4F mRNA | CTD | PMID:19162173 | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of CLEC4F mRNA | CTD | PMID:23608068 | pravastatin | decreases expression | EXP | | 6480464 | Pravastatin results in decreased expression of CLEC4F mRNA | CTD | PMID:27225895 | pravastatin | decreases expression | ISO | RGD:621062 | 6480464 | Pravastatin results in decreased expression of CLEC4F mRNA | CTD | PMID:27225895 | resveratrol | multiple interactions | ISO | RGD:621062 | 6480464 | [resveratrol co-treated with Streptozocin] results in increased expression of CLEC4F mRNA | CTD | PMID:25905778 | resveratrol | multiple interactions | EXP | | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CLEC4F mRNA] | CTD | PMID:31298478 | rotenone | decreases expression | ISO | RGD:621062 | 6480464 | Rotenone results in decreased expression of CLEC4F mRNA | CTD | PMID:28374803 | senecionine | decreases expression | ISO | RGD:621062 | 6480464 | senecionine results in decreased expression of CLEC4F mRNA | CTD | PMID:32419051 | Senkirkine | decreases expression | ISO | RGD:621062 | 6480464 | senkirkine results in decreased expression of CLEC4F mRNA | CTD | PMID:32419051 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of CLEC4F mRNA | CTD | PMID:23221170 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CLEC4F protein | CTD | PMID:29044176 | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of CLEC4F mRNA | CTD | PMID:27862939 | streptozocin | multiple interactions | ISO | RGD:621062 | 6480464 | [resveratrol co-treated with Streptozocin] results in increased expression of CLEC4F mRNA | CTD | PMID:25905778 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CLEC4F mRNA | CTD | PMID:27339419 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CLEC4F mRNA | CTD | PMID:31919559 | theophylline | decreases expression | ISO | RGD:1354444 | 6480464 | Theophylline results in decreased expression of CLEC4F mRNA | CTD | PMID:18951874 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of CLEC4F mRNA | CTD | PMID:31298478 | titanium dioxide | multiple interactions | EXP | | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CLEC4F mRNA] | CTD | PMID:31298478 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CLEC4F mRNA | CTD | PMID:19448997 | triphenyl phosphate | decreases expression | ISO | RGD:621062 | 6480464 | triphenyl phosphate results in decreased expression of CLEC4F mRNA | CTD | PMID:30589522 | |